{"slug":"tirzepatide-trigeminal","verification":{"valid":true,"entries":2,"head":"1ffcce964c327541eb0d21bad4157ee6518175461697442443d39e289acf7704"},"energy":{"passes":2,"tokens_in":11330,"tokens_out":3264,"tokens_total":14594,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"1ffcce964c327541eb0d21bad4157ee6518175461697442443d39e289acf7704"},"provenance":[{"ts":"2026-06-29T22:36:59.585Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tirzepatide for Trigeminal\nSlug: tirzepatide-trigeminal\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tirzepatide\",\"name\":\"Tirzepatide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tirzepatide\",\"name\":\"Tirzepatide\",\"section_title\":\"Why Tirzepatide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\",\"**What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\",\"**Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n2. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n3. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition ","response":"{\n  \"slug\": \"tirzepatide-trigeminal\",\n  \"title\": \"Tirzepatide for Trigeminal Issues: Metabolic Load Evidence Review\",\n  \"body\": \"## What's breaking down\\nTrigeminal neuralgia involves sharp facial pain from irritation or compression of the trigeminal nerve branches. Common contributors include vascular pressure on the nerve root, inflammation, or heightened nerve sensitivity. In people carrying extra body weight, systemic metabolic stress can add to overall inflammation and mechanical strain on tissues, including around the head and neck. This creates a repair-versus-degeneration imbalance where ongoing load or inflammatory signals outpace the body's ability to calm nerve activity. No direct degeneration profile matches the slug exactly, so layers center on metabolic and weight-related factors that may overlap with nerve sensitivity.\\n\\n## Why Tirzepatide might help you\\n1. What keeps failing: The same pattern of excess body weight increasing compressive forces across the body, including potential added stress on facial and cranial structures through inflammation or posture shifts.\\n2. What Tirzepatide is studied to do: It activates GLP-1 and GIP receptors and drives substantial weight reduction in clinical settings.\\n3. Therefore for you: If excess weight contributes to your metabolic or inflammatory load layer, Tirzepatide targets that specific repair pathway by lowering overall body mass rather than directly numbing nerve signals.\\n\\nWeight loss from tirzepatide reduces total body load. Research on similar GLP-1 agonists shows each pound lost can ease several pounds of compressive force in load-bearing areas; the principle extends to systemic effects that may ease inflammatory pressure elsewhere.\\n\\n## How these fit together\\nSingle-compound focus. Tirzepatide addresses the metabolic load and body weight layer. If your profile later includes other peptides, they would target separate degeneration layers such as direct nerve repair or sleep-related recovery. Here ","tokens_in":11330,"tokens_out":3264,"cost":0,"prev":"genesis","hash":"4ad3b56251d557b0126bd390ce77efe246333b60964df3ec173e49fba000a08e"},{"ts":"2026-07-17T02:43:20.779Z","model":"owner","action":"voxel_divide","prompt":"","input":"tirzepatide-trigeminal","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4ad3b56251d557b0126bd390ce77efe246333b60964df3ec173e49fba000a08e","hash":"1ffcce964c327541eb0d21bad4157ee6518175461697442443d39e289acf7704"}]}